Professional paper - Letter to the editor
Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing
European Journal of Clinical Pharmacology, 77 (2021), 6; 935-937. https://doi.org/10.1007/s00228-020-03085-7


Linked objects
COVID-19 | Virtual collection
Cite this document

Trkulja, V. (2021). Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing. European Journal of Clinical Pharmacology, 77. (6), 935-937. doi: 10.1007/s00228-020-03085-7

Trkulja, Vladimir. "Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing." European Journal of Clinical Pharmacology, vol. 77, no. 6, 2021, pp. 935-937. https://doi.org/10.1007/s00228-020-03085-7

Trkulja, Vladimir. "Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing." European Journal of Clinical Pharmacology 77, no. 6 (2021): 935-937. https://doi.org/10.1007/s00228-020-03085-7

Trkulja, V. (2021) 'Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing', European Journal of Clinical Pharmacology, 77(6), pp. 935-937. doi: 10.1007/s00228-020-03085-7

Trkulja V. Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing. European Journal of Clinical Pharmacology [Internet]. 2021 January 06 [cited 2024 December 02];77(6):935-937. doi: 10.1007/s00228-020-03085-7

V. Trkulja, "Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing", European Journal of Clinical Pharmacology, vol. 77, no. 6, pp. 935-937, January 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:524286. [Accessed: 02 December 2024]

Please login to the repository to save this object to your list.